title: Can we prevent fatal liver failure under valproate?
authors.forename: M M
authors.initials: MM
authors.lastname: Schmid
authors.forename: B J
authors.initials: BJ
authors.lastname: Connemann
authors.forename: R C
authors.initials: RC
authors.lastname: Wolf
authors.forename: C
authors.initials: C
authors.lastname: Flechtenmacher
authors.forename: C
authors.initials: C
authors.lastname: Eisenbach
authors.forename: C
authors.initials: C
authors.lastname: Schönfeldt-Lecuona
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000188:drug therapy*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008099:Liver / Q000473:pathology; D017114:Liver Failure, Acute / Q000139:chemically induced* / Q000473:pathology / Q000517:prevention & control*; D008111:Liver Function Tests; D008875:Middle Aged; D014635:Valproic Acid / Q000009:adverse effects*
chemical_list: D000927:Anticonvulsants; D014635:Valproic Acid